KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study.Blood AdvPMID 34477816PMC85252282021-Sep-140.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.JAMAPMID 34519801PMC84415932021-Sep-141.00命中用户提供的消化道肿瘤阳性参考集。待处理
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.JAMAPMID 34519802PMC84415912021-Sep-140.98未发现恶性肿瘤人群证据。待处理
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.J Clin OncolPMID 34133211PMC84258472021-Sep-101.00命中用户提供的消化道肿瘤阳性参考集。待处理
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis.J Clin OncolPMID 34138638无 PMCID2021-Sep-100.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial.J Clin OncolPMID 34197181PMC84258422021-Sep-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection.Sci RepPMID 34504196PMC84295422021-Sep-090.95Eligible study type (oncology, human, randomized, Phase 3, drug intervention, original results) but excluded because it lacks a primary/key secondary time-to-event efficacy endpoint.待处理
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.VaccinePMID 34315611无 PMCID2021-Sep-070.98未发现恶性肿瘤人群证据。待处理
Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial.J Natl Cancer InstPMID 33606023无 PMCID2021-Sep-040.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.Arthritis Res TherPMID 34481517PMC84180442021-Sep-040.98未发现恶性肿瘤人群证据。待处理
Clinical and Histological Characterization of Toxic Keratopathy From Depatuxizumab Mafodotin (ABT-414), an Antibody-Drug Conjugate.CorneaPMID 33201054无 PMCID2021-Sep-010.99记录类型属于综述、Meta 分析、社论、评论、病例或指南。待处理
Management of fatigue with physical activity and behavioural change support in vasculitis: a feasibility study.Rheumatology (Oxford)PMID 33369680PMC84100062021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors.Rheumatology (Oxford)PMID 33479721PMC84100002021-Sep-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial.RetinaPMID 33782365PMC83842512021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.Neuro OncolPMID 33914057PMC84088622021-Sep-010.90Eligible: This is a primary report of a randomized Phase III oncology trial (EORTC CATNON) in humans with a drug-containing intervention (temozolomide) and a primary time-to-event efficacy endpoint (overall survival).待处理
Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study.Blood Coagul FibrinolysisPMID 33973891无 PMCID2021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.Am J HematolPMID 34050972无 PMCID2021-Sep-010.85The study is a Phase III randomized trial of a drug combination in oncology, but the reported results are focused exclusively on patient-reported quality of life outcomes (EORTC QLQ-C30, MDASI). No time-to-event efficacy endpoint (like OS or PFS) is reported or analyzed in this specific abstract. Therefore, it does not meet the primary criterion for inclusion as a KM/HR study.待处理
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.Am J HematolPMID 34062004PMC84571162021-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.Clin Cancer ResPMID 34108184PMC94014972021-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.Clin Cancer ResPMID 34112708无 PMCID2021-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials.Eur J Pharm SciPMID 34116176无 PMCID2021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines.Pediatr Infect Dis JPMID 34117198PMC83570452021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit: A Secondary Analysis of a Randomized Clinical Trial.Ann SurgPMID 34132695PMC84802332021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.Am J HematolPMID 34161616PMC84571362021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.JAMA PsychiatryPMID 34190962PMC82463372021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.JAMA OncolPMID 34264305PMC82836662021-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.JAMA OncolPMID 34264316PMC82836672021-Sep-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA OncolPMID 34292305PMC82993672021-Sep-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.J NeuroophthalmolPMID 34310464PMC83667572021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.JAMA DermatolPMID 34347860PMC83400152021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.J Acquir Immune Defic SyndrPMID 34397746PMC83570462021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.J NeuroophthalmolPMID 34415265PMC83667612021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.Am J GastroenterolPMID 34465695无 PMCID2021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.JAMA Netw OpenPMID 34477854PMC84177582021-Sep-010.98未发现恶性肿瘤人群证据。待处理
AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data.J Drugs DermatolPMID 34491022无 PMCID2021-Sep-010.98未发现恶性肿瘤人群证据。待处理
Low-dose fractionated radiation with induction docetaxel and cisplatin followed by concurrent cisplatin and radiation therapy in locally advanced nasopharyngeal cancer: A randomized phase II-III trial.Hematol Oncol Stem Cell TherPMID 32504593无 PMCID2021-Sep0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.Dig Liver DisPMID 33060043无 PMCID2021-Sep0.95The study is a Phase III randomized trial of a drug intervention in humans, but it investigates a non-oncology condition (paediatric NAFLD) and does not report a time-to-event efficacy endpoint (OS, PFS, DFS, etc.) as a primary or key secondary outcome. The endpoints are inflammatory and oxidative stress biomarkers, not survival or progression metrics.待处理
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.GutPMID 33199443PMC83558762021-Sep0.45The study meets most inclusion criteria: it is a Phase III, randomized, human oncology trial with a drug-containing intervention (panitumumab + chemotherapy). However, the abstract does not provide explicit reporting of a primary or key secondary time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, or TTP, nor does it mention Kaplan-Meier analysis or hazard ratios. The deterministic review correctly flagged a lack of time-to-event signal, so eligibility cannot be confirmed without verifying the full-text for the presence of these results.待处理
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.Mult SclerPMID 33205682PMC84148182021-Sep0.98未发现恶性肿瘤人群证据。待处理
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.Strahlenther OnkolPMID 33320286PMC83976312021-Sep0.45The record describes a secondary analysis of guideline impact and adoption within a Phase III randomized controlled trial (HYPOSIB). While it is a definitive oncology trial, the reported outcomes are related to treatment adoption and patient characteristics, not the survival, progression, recurrence, death, or other efficacy outcomes required for inclusion.待处理
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.Bipolar DisordPMID 33368969无 PMCID2021-Sep0.98未发现恶性肿瘤人群证据。待处理
Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.Sleep BreathPMID 33394323PMC83766932021-Sep0.98未发现恶性肿瘤人群证据。待处理
RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.Clin Lung CancerPMID 33736940无 PMCID2021-Sep0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.Clin Transl OncolPMID 33738704无 PMCID2021-Sep0.90The record is a Phase II randomized trial in oncology with a drug intervention and original results. However, it is excluded because it does not meet the key eligibility criteria: it is not a Phase III or definitive Phase II/III trial, and its primary and secondary endpoints (incidence and duration of oral mucositis) are not a primary/key secondary time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, or TTP, nor do the results include a Kaplan-Meier or HR analysis for such an endpoint.待处理
Efficacy and Safety of Diclofenac-Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan.Arthritis RheumatolPMID 33749997PMC84568652021-Sep0.98未发现恶性肿瘤人群证据。待处理
Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.Am J OphthalmolPMID 33773984无 PMCID2021-Sep0.98未发现恶性肿瘤人群证据。待处理
Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.Clin Transl OncolPMID 33792839无 PMCID2021-Sep0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.Breast CancerPMID 33797023PMC83549072021-Sep0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.J Neurol Neurosurg PsychiatryPMID 33879535PMC83723982021-Sep0.98未发现恶性肿瘤人群证据。待处理
The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically Integrated, Cluster, Randomized Trial.J UrolPMID 33904798PMC84419912021-Sep0.93干预为非药物单独策略,未满足药物干预要求。待处理